Answers are grounded in this paper and cite their sources.
Pain and variable uptake remain practical barriers to needle-based delivery. Device-level vibration has emerged as a simple strategy for improving tolerability and dispersion, but its fluid-mechanical basis remains incomplete. Using a lattice Boltzmann model with a porous-media skin surrogate, we applied time-periodic inlet pressures at 0%, 16.6% (ΔP1), and 35.1% (ΔP2) amplitudes to Newtonian, model shear-thinning, and clinically measured protein formulations. We quantified the wall shear stress, wetted area, dispersion length, and pressure cost over one cycle. Vibration increased the normalized wetted area by 10.6% for Newtonian flow and by 15.9% and 21.3% for the non-Newtonian cases at ΔP1 and ΔP2, respectively, while advancing the penetration front and lateral dispersion. The one-cycle pressure cost per wetted area decreased by 3.9% for Newtonian flow and by 5.96% and 7.80% for non-Newtonian flows. For shear-thinning fluids, the wall-shear history was reshaped, with a brief early amplification and late-phase mean reductions of 10.3% and 13.3% at ΔP1 and ΔP2. These results establish a fluid-mechanical mechanism linking clinically relevant vibration amplitudes to reduced sustained shear exposure, deeper and broader depot formation, and improved conditions for drug uptake.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: